This systematic review aimed to provide an overview of the clinical profile and outcome of
COVID-19 infection in patients with hemoglobinopathy. The rate of COVID-19 mortality and …

Abstract Coronavirus disease 19 (COVID-19) is an infectious disease caused by severe
acute respiratory coronavirus 2 (SARS-CoV-2) causing acute systemic disorders and multi …

Background The ongoing COVID-19 pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has led to high morbidity and mortality worldwide …

Australia and New Zealand have achieved excellent community control of COVID‐19
infection. In light of the imminent COVID‐19 vaccination roll out in both countries …

During the coronavirus-19 disease (COVID-19) pandemic, several studies were performed
to determine the mortality and incidence rates of coronavirus infection among patients with …

Background: The assignment of mortality risk from SARS-CoV-2 virus (COVID-19) to
vulnerable patient groups is an important step toward containment of the pandemic …

Introduction Because of iron overload complications, thrombosis and infectious
predisposition, patients with severe forms of thalassemia are likely to be at increased risk of …

Context: COVID-19 results in an imbalance between procoagulant and anticoagulant
homeostatic mechanisms that could be complicated with thrombotic events. In β-thalassemia …

This systematic review and meta-analysis synthesized the evidence on the impacts of
demographics and comorbidities on the clinical outcomes of COVID-19, as well as the …

Thalassemia is a Mendelian inherited blood disease caused by α-and β-globin gene
mutations, known as one of the major health problems of Mediterranean populations. Here …